You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The study will combine cognitive assessments with genetic data and survey responses to gain insights into the causes of these two mental health conditions.
Researchers in Australia hope the genetic study will help take the guesswork out of prescribing medications for depression, the Hack says.
The international team of researchers also examined the genetic ties between personality traits and psychiatric disorders.
23andMe's database has enabled it to link loci to disease and fuel better understanding of diseases like depression, KQED Science says.
The company has recently launched its first diagnostic test on the market and is developing a second, which is currently in clinical trials.
In Nature this week: loci linked to major depressive disorder, and more.
With genotypes for hundreds of thousands of individuals, investigators uncovered 15 loci linked to major depressive disorder in individuals with European ancestry.
The firm plans to launch testing in the US this fall through Atlanta-based Alpha Genomix, and is looking for similar partners in Asia for a new Asia-specific panel.
Researchers identified Neanderthal alleles associated with human conditions using genotypic and phenotypic information in health records for more than 28,000 individuals.
The company's test, CNSDose, incorporates multiple genes involved in metabolism of antidepressants in the liver and how they cross into the brain via the blood-brain-barrier.
The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.
NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.
Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.
In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.